Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-22-051912

Director bought 88,797 shares at an average $1.24 ($110,500)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-09-29 Purchase : show line 1 in the form +13,800 $1.19 $16,422 286,917 D
2022-09-30 Purchase : show line 2 in the form +33,199 $1.26 $41,831 320,116 D
2022-10-03 Purchase : show line 3 in the form +41,798 $1.25 $52,248 361,914 D
Open-market purchases · 88,797 sh · avg $1.24 · $110,500
Loading xslF345X03/doc4.xml…